Vestibular migraine: Diagnostic criteria1.

Bárány Society International Headache Society Migraine diagnostic criteria dizziness vertigo vestibular

Journal

Journal of vestibular research : equilibrium & orientation
ISSN: 1878-6464
Titre abrégé: J Vestib Res
Pays: Netherlands
ID NLM: 9104163

Informations de publication

Date de publication:
2022
Historique:
pubmed: 2 11 2021
medline: 1 4 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

This paper presents diagnostic criteria for vestibular migraine, jointly formulated by the Committee for Classification of Vestibular Disorders of the Bárány Society and the Migraine Classification Subcommittee of the International Headache Society (IHS). It contains a literature update while the original criteria from 2012 were left unchanged. The classification defines vestibular migraine and probable vestibular migraine. Vestibular migraine was included in the appendix of the third edition of the International Classification of Headache Disorders (ICHD-3, 2013 and 2018) as a first step for new entities, in accordance with the usual IHS procedures. Probable vestibular migraine may be included in a later version of the ICHD, when further evidence has accumulated. The diagnosis of vestibular migraine is based on recurrent vestibular symptoms, a history of migraine, a temporal association between vestibular symptoms and migraine symptoms and exclusion of other causes of vestibular symptoms. Symptoms that qualify for a diagnosis of vestibular migraine include various types of vertigo as well as head motion-induced dizziness with nausea. Symptoms must be of moderate or severe intensity. Duration of acute episodes is limited to a window of between 5 minutes and 72 hours.

Identifiants

pubmed: 34719447
pii: VES201644
doi: 10.3233/VES-201644
pmc: PMC9249276
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Subventions

Organisme : Medical Research Council
ID : MR/P006493/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T023880/1
Pays : United Kingdom

Références

J Vestib Res. 2021;31(1):1-9
pubmed: 33386837
J Clin Neurosci. 2004 May;11(4):384-8
pubmed: 15080953
Funct Neurol. 2003 Apr-Jun;18(2):97-101
pubmed: 12911141
J Vestib Res. 2012;22(4):167-72
pubmed: 23142830
Front Neurol. 2014 Dec 15;5:265
pubmed: 25566172
Audiol Neurootol. 2010;15(4):241-6
pubmed: 19893305
J Vestib Res. 2015;25(1):1-7
pubmed: 25882471
J Vestib Res. 2016;26(5-6):409-415
pubmed: 28262641
Neurology. 2001 Feb 27;56(4):436-41
pubmed: 11222783
Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2661-7
pubmed: 24121780
J Vestib Res. 2009;19(1-2):1-13
pubmed: 19893191
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Am J Med Genet. 2001 May 15;100(4):287-91
pubmed: 11343320
Headache. 2018 Apr;58(4):534-544
pubmed: 29205326
Otol Neurotol. 2008 Jan;29(1):93-6
pubmed: 18046258
Neurology. 2019 Jun 11;92(24):e2743-e2753
pubmed: 31092626
Neurology. 2009 Aug 25;73(8):638-42
pubmed: 19704084
Otol Neurotol. 2018 Sep;39(8):1037-1044
pubmed: 30020261
Otol Neurotol. 2012 Sep;33(7):1235-44
pubmed: 22801040
J Vestib Res. 2017;27(4):191-208
pubmed: 29036855
Headache. 2019 May;59(5):727-740
pubmed: 30737783
Neurology. 2012 Oct 9;79(15):1607-14
pubmed: 23019266
Laryngoscope. 2021 Jan;131(1):186-194
pubmed: 32083732
Brain. 1984 Dec;107 ( Pt 4):1123-42
pubmed: 6334543
Cephalalgia. 2016 Apr;36(5):454-62
pubmed: 26224714
J Vestib Res. 2021;31(5):327-344
pubmed: 33646187
Neurology. 2002 Dec 10;59(11):1700-4
pubmed: 12473755
Headache. 1981 Sep;21(5):227-31
pubmed: 7287423
Neurology. 2006 Sep 26;67(6):1028-33
pubmed: 17000973
Behav Neurol. 2016;2016:3182735
pubmed: 27651559
Auris Nasus Larynx. 2020 Oct;47(5):747-751
pubmed: 32178946

Auteurs

Thomas Lempert (T)

Department of Neurology, Schlosspark-Klinik, Berlin, Germany.

Jes Olesen (J)

Danish Headache Center and Department of Neurology, University of Copenhagen, Copenhagen, Denmark.

Joseph Furman (J)

Departments of Otolaryngology and Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

John Waterston (J)

Monash University Department of Neuroscience, Alfred Hospital, Melbourne, Australia.

Barry Seemungal (B)

Department of Clinical Neuroscience, Charing Cross Hospital, London, UK.

John Carey (J)

Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Alexander Bisdorff (A)

Department of Neurology, Centre Hospitalier Emile Mayrisch, Esch-sur-Alzette, Luxembourg.

Maurizio Versino (M)

Neurology and Stroke Unit, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy.
University of Insubria, Varese, Italy.

Stefan Evers (S)

Department of Neurology, Krankenhaus Lindenbrunn, Coppenbrügge, Germany.

Amir Kheradmand (A)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

David Newman-Toker (D)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH